Clinical Trials · NCT02360384
Caecal pH as a Biomarker for Irritable Bowel Syndrome
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Wingate Institute of Neurogastroenterology
- Enrollment
- 48
- Start date
- Nov 2015
- Locations
- 1 site, United Kingdom
- Primary endpoint
- To evaluate the change in pH around the ileocaecal valve in response to dietary intervention or linaclotide.